• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

XTL Biopharmaceuticals Ltd

+ Add to Watchlist

H2K1:GR

1.700 EUR 0.002 0.12%

As of 07:58:11 ET on 11/27/2014.

Snapshot for XTL Biopharmaceuticals Ltd (H2K1)

Open: 1.653 Day's Range: 1.653 - 1.751 Volume: 0
Previous Close: 1.698 52wk Range: 1.241 - 3.431 1-Yr Rtn: -43.33%

Stock Chart for H2K1

No chart data available.
  • H2K1:GR 1.700
  • 1M
  • 1Y
1.698
Interactive H2K1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for H2K1

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 19.80
Shares Outstanding (M) 11.64
30 Day Average Volume 67
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for H2K1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for H2K1

XTL Biopharmaceuticals, Ltd. is a biopharmaceutical company. The Company offers acquisition and development of pharmaceutical products for the treatment of unmet medical needs, particularly the treatment of multiple myeloma and hepatitis X.

Joshua LevineChief Executive OfficerDavid KestenbaumChief Financial Officer
Moshe MittelmanDirector:Medical
More Company Profile & Key Executives for H2K1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil